These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 19114099)

  • 1. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
    Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
    Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
    Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of ubidecarenone transdermal delivery systems.
    Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of permeation enhancers and organic acids on the skin permeation of indapamide.
    Ren C; Fang L; Li T; Wang M; Zhao L; He Z
    Int J Pharm; 2008 Feb; 350(1-2):43-7. PubMed ID: 17888599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
    Prasad Verma PR; Chandak AR
    Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of matrix type transdermal patch of ethinylestradiol and medroxyprogesterone acetate for anti-implantation activity in female Wistar rats.
    Agrawal SS; Pruthi JK
    Contraception; 2011 Nov; 84(5):533-8. PubMed ID: 22018130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
    Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
    Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F
    Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
    Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
    Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.